COVID-19 ICU patients may face higher superbug risk
NCT ID NCT04378842
First seen May 01, 2026 · Last updated Jun 15, 2026 · Updated 7 times
Summary
This study examined whether being in the ICU with COVID-19 made patients more likely to pick up dangerous, drug-resistant bacteria. Researchers tracked 368 critically ill adults to compare infection rates before and during the pandemic. The goal was to understand if COVID-19 changed the spread of these superbugs in ICUs, which can help hospitals improve safety measures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CH LENS
Lens, France
-
Ch Bethune
Béthune, France
-
Chu Amiens Picardie
Amiens, France
-
Grand Hopital de L'Est Francilien
Jossigny, France
-
Hospices Civils de Lyon
Lyon, France
-
Hospices Civils de Lyon (Pierre Bénite,Edouard Herriot, La Croix Rousse)
Lyon, France
-
Hôpital Roger Salengro, ICU, CHU Lille
Lille, 59037, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.